Trial intelligence / Profile preview

D-ALBA frontline dasatinib followed by blinatumomab in adult Ph-positive ALL

2016-001083-11Phase 2Completed

Sponsor

GIMEMA

Start

Nov 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1